Dexmedetomidine infusion for the management of opioid-induced hyperalgesia.
Belgrade
Miles
M
Fairview Pain Management Center, University of Minnesota Medical Center, Minneapolis, Minnesota, USA. mbelgra1@fairview.org
Hall
Sara
S
D000293:Adolescent; D058647:Adrenergic alpha-2 Receptor Agonists / Q000627:therapeutic use*; D000328:Adult; D000465:Algorithms; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use*; D000701:Analgesics, Opioid / Q000009:adverse effects*; D002648:Child; D020927:Dexmedetomidine / Q000627:therapeutic use*; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D006930:Hyperalgesia / Q000139:chemically induced* / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D055815:Young Adult
D058647:Adrenergic alpha-2 Receptor Agonists; D018712:Analgesics, Non-Narcotic; D000701:Analgesics, Opioid; D020927:Dexmedetomidine